Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 425 of 1467 entries
View as:

Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01795183 Org: User:
Start: 11/30/12 End: 12/31/13 Due: 12/31/14

Real World and Epidemiology Study of Medically Attended Chlamydia Trachomatis Among Adults in Germany

Phase: N/A Priority: Normal
NCT ID: NCT07002047 Org: User:
Start: 03/13/25 End: 02/17/26 Due: 02/17/27

Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial Function

Phase: N/A Priority: Normal
NCT ID: NCT00648453 Org: User:
Start: 12/31/02 End: 04/30/04 Due: 04/30/05

Satisfaction and Compliance of Risedronate in PMO

Phase: N/A Priority: Normal
NCT ID: NCT00549965 Org: User:
Start: 10/31/03 End: - Due: -

Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00397098 Org: User:
Start: 11/30/06 End: 09/30/07 Due: 09/30/08

Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation

Phase: N/A Priority: Normal
NCT ID: NCT00790101 Org: User:
Start: 06/30/04 End: 10/31/04 Due: 10/31/05

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)

Phase: N/A Priority: Normal
NCT ID: NCT03529123 Org: User:
Start: 06/19/18 End: 11/25/19 Due: 11/25/20

Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide

Phase: N/A Priority: Normal
NCT ID: NCT02379390 Org: User:
Start: 06/17/15 End: 05/10/18 Due: 05/10/19

Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)

Phase: N/A Priority: Normal
NCT ID: NCT02545842 Org: User:
Start: 09/07/15 End: 04/20/18 Due: 04/20/19

Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH)

Phase: N/A Priority: Normal
NCT ID: NCT01617655 Org: User:
Start: 06/30/12 End: 01/31/15 Due: 01/31/16

Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days

Phase: N/A Priority: Normal
NCT ID: NCT00237445 Org: User:
Start: 11/30/05 End: 09/30/06 Due: 09/30/07

Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)

Phase: N/A Priority: Normal
NCT ID: NCT00642915 Org: User:
Start: 06/30/03 End: 07/31/04 Due: 07/31/05

Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00756847 Org: User:
Start: 09/30/08 End: 10/31/12 Due: 10/31/13

Stilnox Treatment in Elderly Patients With Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00359229 Org: User:
Start: 07/31/06 End: - Due: -

Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00819728 Org: User:
Start: 06/30/00 End: 01/31/03 Due: 01/31/04

Dermacyd Infantile - Acceptability.

Phase: N/A Priority: Normal
NCT ID: NCT00881270 Org: User:
Start: 03/31/09 End: 03/31/09 Due: 03/31/10

Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT06975878 Org: User:
Start: 05/22/25 End: 08/18/27 Due: 08/18/28

A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work

Phase: N/A Priority: Normal
NCT ID: NCT06290128 Org: User:
Start: 07/12/24 End: 10/12/27 Due: 10/12/28

Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT06824181 Org: User:
Start: 02/27/25 End: 08/26/27 Due: 08/26/28

Pharmacodynamics Assessment Study After Single Subcutaneous Dose Of SAR113244 Versus Placebo In Lupus Male And Female Patients

Phase: N/A Priority: Normal
NCT ID: NCT02331810 Org: User:
Start: 04/30/16 End: 05/31/17 Due: 05/31/18

Dermacyd Infantile (Lactic Acid) - Photo Evaluation.

Phase: N/A Priority: Normal
NCT ID: NCT00881348 Org: User:
Start: 02/28/09 End: 03/31/09 Due: 03/31/10

A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT05712278 Org: User:
Start: 06/16/23 End: 03/12/24 Due: 03/12/25

Dermacyd Breeze (Lactic Acid) Pocket BR - Compatibility

Phase: N/A Priority: Normal
NCT ID: NCT00784121 Org: User:
Start: 10/31/08 End: - Due: -

Description of Patients With Type 1 Diabetes Treated With Teplizumab

Phase: N/A Priority: Normal
NCT ID: NCT06892002 Org: User:
Start: 02/11/25 End: 07/26/25 Due: 07/26/26

Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT01459809 Org: User:
Start: 02/29/12 End: 01/31/14 Due: 01/31/15